Vyvanse for binge eating disorder

http://www.fiercepharmamarketing.com/story/shires-vyvanse-brand-team-draws-fire-aggressive-binge-eating-push/2015-02-25

Shire is pushing full steam ahead to get the word out on binge eating disorder (BED), the new indication it snagged for blockbuster Vyvanse last month…

But all of these activities worry some medical professionals, considering that Vyvanse is essentially an amphetamine, The New York Times notes. And amphetamines have a long history of triggering abuse in overweight patients, a category that describes about 80% of binge-eaters, according to Shire–though the company notes that Vyvanse shouldn’t be used as a weight loss or obesity treatment…

“Now we have another reason for the public to learn about the glories of amphetamine–it’s very worrisome,” one behavioral pediatrician told the paper. The chief medical officer of Phoenix House, a drug treatment organization, remarked that there are “so many reasons to be concerned about this.”

What, no mention of this person’s name?  Could that be… Mr. Kolodny?

Shire’s track record isn’t helping much. Last fall, the pharma shelled out $56.6 million to settle federal charges that it crossed the line while promoting Vyvanse, the Times notes. Among the claims was that Shire played down Vyvanse’s addiction potential–an allegation the company denies…

If you don't comment, I'll just assume you agree with me

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s